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Introduction
Proliferating  cell  nuclear  antigen  (PCNA)  is  a  member  of   
the conserved sliding clamp family of proteins. It is essential 
for chromosomal DNA replication and important for several 
DNA transactions, such as DNA repair, epigenetic modifica-
tion, chromatin assembly and remodeling, sister chromatid 
cohesion, and cell cycle control (Moldovan et al., 2007). Nu-
merous proteins involved in these processes are localized in 
so-called replication factories, and many of these proteins 
interact with PCNA through the conserved sequence called the 
PCNA-interacting peptide (PIP) box (QxxL/I/MxxHF/DF/Y; 
Warbrick, 2000). However, several PCNA-binding proteins   
do not contain a PIP box (Fan et al., 2004; Moldovan et al., 
2007). Furthermore, posttranslational modifications (PTMs) 
of PCNA have been reported to regulate the affinity to its 
binding partners, as illustrated by polymerase switch (Lehmann 
et al., 2007).
Human cells are exposed to alkylating compounds pro-
duced endogenously from environmental sources and drugs 
used  in  cancer  treatment  (Drabløs  et  al.,  2004).  Proteins   
involved in DNA repair and cell cycle control are interesting 
targets to increase the efficacy of chemotherapy (Helleday   
et al., 2008). The DNA damage introduced, such as alkylation 
adducts and interstrand cross-links, may lead to miscoding, 
replication arrest, double-strand breaks, and/or cell death. The 
simpler lesions, such as methylated bases, are repaired by base 
excision repair (BER), oxidative demethylation, or methyl 
transfer, depending on the type of damage (Sedgwick et al., 
2007). The BER enzyme 3-methyladenine DNA glycosylase 
(AAG/MPG; removes 3meA) and the oxidative demethylase 
human AlkB homologue 2 (hABH2; repairs 1meA and 3meC) 
are both localized in proximity of replication foci (Aas et al., 
2003; Xia et al., 2005). Although MPG contains an “inverted” 
PIP box sequence for interaction with PCNA, no PIP box is 
found in hABH2.
In this study, we demonstrate that hABH2 interacts with 
PCNA through a novel PCNA-interacting motif, AlkB homo-
logue 2 PCNA-interacting motif (APIM), and that APIM is a 
functional PCNA-binding motif important for several proteins 
involved in DNA maintenance and cell cycle regulation after 
DNA damage.
  N
umerous proteins, many essential for the DNA 
replication machinery, interact with proliferating 
cell nuclear antigen (PCNA) through the PCNA-
interacting peptide (PIP) sequence called the PIP box. We 
have  previously  shown  that  the  oxidative  demethylase   
human AlkB homologue 2 (hABH2) colocalizes with PCNA 
in replication foci. In this study, we show that hABH2 inter-
acts with a posttranslationally modified PCNA via a novel 
PCNA-interacting motif, which we term AlkB homologue 2 
PCNA-interacting motif (APIM). We identify APIM in 
>200 other proteins involved in DNA maintenance, tran-
scription, and cell cycle regulation, and verify a functional 
APIM  in  five  of  these.  Expression  of  an  APIM  peptide   
increases the cellular sensitivity to several cytostatic agents 
not accounted for by perturbing only the hABH2–PCNA 
interaction. Thus, APIM is likely to mediate PCNA binding 
in many proteins involved in DNA repair and cell cycle 
control during genotoxic stress.
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Tyr could substitute for Phe at this position, whereas Ala abol-
ished the interaction (Fig. 2 B and not depicted). We verified 
the sequence specificity for the PCNA interaction in vivo by 
expressing the conserved amino acids 1–7 of hABH2, and vari-
ants in which Phe4 was substituted by Tyr, Trp, or Ala, in fusion 
with YFP and tested their subnuclear localization. Expressed 
fusion proteins containing an aromatic amino acid in position 4 
colocalized with PCNA when expressed alone (Fig. 2 C, rows 
1 and 2) and when coexpressed with CFP-PCNA (Fig. 2 C, 
rows 3–5). Analogous to what was found in dot blot assays, the 
F4A mutation severely reduced the colocalization with PCNA 
(Fig. 2 C, row 6). By measuring fluorescence resonance energy 
transfer (FRET), we found that both full-length hABH2-YFP 
and hABH21–10-YFP as well as hABH21–7F4W-YFP are in very 
close proximity with CFP-PCNA because fluorescent tags must 
be <100 Å apart to give positive FRET (Mátyus, 1992).
To further investigate the proximity between hABH2 and   
PCNA, we performed in vivo cross-linking in cells stably ex-
pressing hABH21–7-YFP-Flag and hABH21–7F4A-YFP-Flag 
using formaldehyde. Formaldehyde induces heat-reversible cross-
links of proteins that are within 2 Å of one another (Vasilescu   
et al., 2004). Extracts from these cells were used for IP with -Flag. 
After elution with Flag peptide, cross-links in half of the samples 
were reversed. In Fig. 2 E (lanes 3 and 11), bands containing both   
PCNA and Flag are identified at molecular masses of 70–75 kD 
(1: PCNA cross-linked to hABH21–7-YFP-Flag), 100–130 kD 
(2: PCNA dimer or trimer cross-linked to hABH21–7-YFP-Flag), 
and 160–190 kD (3: PCNA trimer cross-linked to two or three 
hABH21–7-YFP-Flag). Bands 1 and 2 are much stronger in the 
IP from cells expressing hABH21–7 wild type (WT) than from 
cells expressing the hABH21–7F4A mutant, and band 3 is not de-
tected in the IP from cells expressing the hABH21–7F4A mutant. 
Notably, after reversal of the cross-links (lanes 4 and 12), only 
PCNA and Flag bands of 35 kD were identified, suggesting that 
the larger bands detected in lanes 3 and 11 were cross-linked with 
hABH21–7-YFP-Flag and PCNA. Together with the FRET, these 
data strongly support a direct interaction between hABH21–7  
and PCNA.
Our data from co-IP experiments (Fig. 1, B–D) indi-
cated that more complexes of hABH2 and PCNA were pulled 
down from chromatin-enriched fractions, suggesting potential 
involvement of PTMs. Therefore, we analyzed the isoform 
distribution of PCNA cross-linked to hABH21–7-YFP-Flag 
by 2D Western blot (WB) analysis and compared it with the 
total repertoire of PCNA isoforms present in the same cell 
extract (Fig. 2 F). We included purified RAD51 as an inter-
nal standard because its isoelectric point (pI; 5.4) is close to 
the pI of unmodified PCNA (4.6). Our results indicate that 
the PCNA variants cross-linked to hABH21–7-YFP-Flag (top 
membrane) are shifted toward a more acidic pI without sig-
nificantly changing the vertical migration. Multiple isoforms 
of PCNA with pI between 4 and 5 have previously been identi-
fied, although the exact nature of most of these modifications 
is not known (Naryzhny, 2008). Most PCNA present in a cell 
(lower membrane), and the low levels (Fig. 2 E, lane 7) of 
PCNA cross-linked to hABH21–7F4A-YFP-Flag (mutant; mid 
membrane), have a higher pI than the PCNA pulled down by 
Results and discussion
The 10 N-terminal amino acids in hABH2 
are essential for colocalization with PCNA
To identify the region in hABH2 responsible for localization in 
replication foci during S phase (Aas et al., 2003), we coexpressed 
PCNA tagged with a blue variant of GFP (CFP-PCNA) and var-
ious hABH2 deletion mutants fused with a yellow GFP variant 
(YFP) because GFP-tagged PCNA is known to form foci rep-
resenting sites of replication (Leonhardt et al., 2000). First, we 
verified that hABH2-YFP colocalized with endogenous PCNA   
similar to coexpressed, tagged PCNA (Fig. 1 A, rows 1 and 2).   
Next, we found that deletion of the 10 N-terminal amino acids   
in hABH2 totally abolished the colocalization with PCNA.   
Remarkably, these 10 amino acids fused to YFP were sufficient 
for colocalization with PCNA (Fig. 1 A, rows 3 and 4). No-
tably, coexpression of CFP-PCNA increased the localization 
of full-length hABH2 (hABH21–261-YFP) but not hABH211–261-
YFP in nuclear foci, suggesting a direct interaction between 
PCNA and hABH2 mediated by the 10 N-terminal amino   
acids of hABH2.
To investigate the potential hABH2–PCNA interaction in 
more detail, soluble and chromatin-enriched protein extracts were 
prepared from cells expressing hABH2-YFP, hABH211–261-YFP, 
or YFP and subjected to coimmunoprecipitation (co-IP) using 
anti-YFP antibodies (-YFP). Notably, low levels of PCNA 
were pulled down from the soluble cell fraction, whereas PCNA 
was readily pulled down from the chromatin-enriched fraction. 
Moreover, removal of the 10 N-terminal residues in hABH2 
markedly decreased the amount of PCNA pulled down (Fig. 1 B). 
The hABH2–PCNA interaction was confirmed by reciprocal 
experiments using extracts from cells expressing YFP-PCNA 
(Fig. 1 C) and also by targeting endogenous PCNA (Fig. 1 D).   
In both cases, more hABH2 was pulled down from the chromatin-
enriched fractions than from the soluble fractions (Fig. 1, C   
and D), even though both proteins were present in the soluble frac-
tion (Fig. 1 D, input). Collectively, these results support the idea 
that hABH2 interacts with PCNA and that the binding sequence 
is contained within hABH2’s 10 N-terminal amino acids. The 
apparent preferential association of hABH2 and PCNA in the 
chromatin-enriched fraction may indicate that a subfraction of 
either of the proteins exists in a PTM form, promoting the inter-
action. Alternatively, the presence of other proteins may medi-
ate the observed interaction. A bridging effect caused by DNA 
interaction was considered less likely because the chromatin-
enriched fraction was subjected to extensive DNase and RNase 
treatment before co-IP.
hABH2 directly interacts with PCNA 
through a novel PCNA-binding motif
Sequence alignment of ABH2s from several species shows   
that the seven N-terminal amino acids are highly conserved 
(Fig. 2 A) and have the apparent consensus Met-Asp-Lys/Arg-
Phe-(Leu/Val/Ile)2-Lys/Arg. The flanking amino acids (8–10) 
are not conserved. Dot blot assays against mutant versions of 
this sequence indicated that the most important determinant for 
binding to PCNA was an aromatic residue at position 4 because 647 A NOVEL PCNA-BINDING MOTIF • Gilljam et al.
hABH21–7-YFP-Flag. PTMs on PCNA may explain why our 
attempts to analyze the PCNA–hABH2 interactions using puri-
fied recombinant full-length proteins in in vitro experiments 
gave inconclusive data.
Collectively, these results reveal a novel PCNA-binding 
site within the conserved seven N-terminal amino acids of 
hABH2. Based on the alignment of the different ABH2s, the dot 
blot assay, and the in vivo imaging results, APIM was defined as 
[KR]-[FYW]-[LIVA]-[LIVA]-[KR].
Overexpression of APIM decapeptide 
fused to YFP reduces repair of 1meA and 
sensitizes cells to DNA alkylation damage
hABH2 is known to repair 1meA and 3meC generated by the 
SN2-alkylating agent methyl methanesulfonate (MMS) (Aas   
et al., 2003; Ringvoll et al., 2006). To examine whether expres-
sion of APIM interfered with the function of hABH2 by per-
turbation of the PCNA binding, we exposed cells expressing   
hABH21–10-YFP or only YFP to MMS and analyzed removal 
of 1meA in DNA by liquid chromatography (LC)/mass spec-
trometry (MS)/MS. Cells were arrested at the G1/S border 
and treated with MMS for 1 h. For arrested cells, a 13% sig-
nificant increase of 1meA was seen in APIM-YFP–expressing 
compared with YFP-expressing cells (Fig. 3 A). This is likely 
the result of reduced removal of 1meA by endogenous hABH2 
during incubation with MMS. These results indicate that the 
hABH2–PCNA interaction is required for efficient removal of 
1meA in cells arrested at the G1/ S transition.
Next, we exposed cell lines expressing hABH21–10-YFP, 
hABH21–7F4A-YFP, and YFP to MMS and measured their   
colony-forming capacity. We found a fivefold decrease in colony-
forming units in cells overexpressing functional hABH21–10-YFP 
compared with the cells expressing mutated APIM and only 
YFP (Fig. 3 B). These results strongly suggest that binding of 
APIM to PCNA increases MMS cytotoxicity. We subsequently 
exposed hABH21–10-YFP– and YFP-expressing cells to MMS 
as well as three other alkylating agents, BCNU (carmustine), 
temozolomide (TMZ), and mitomycin C (MMC), and measured 
cell growth for 4 d (MTT assay [3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide]). Unlike MMS, the other   
alkylating agents are believed to introduce damage not repaired 
by hABH2 but by several different repair pathways, includ-
ing direct methyl transfer by O
6-methylguanine-DNA methyl-
transferase, nucleotide excision repair, BER, mismatch repair, 
and homologous recombination (Sedgwick et al., 2007). Over 
expression of hABH21–10-YFP had little effect on the growth 
rate in untreated cells, whereas it strongly sensitized cells to all 
the alkylating agents (Fig. 3 C). These results suggested that 
the hypersensitivity to genotoxic agents was caused by inhibit-
ing the function not only of hABH2 but also of other proteins 
involved in genome maintenance.
Figure 1.  The 10 N-terminal amino acids of hABH2 are important for 
interaction  with  PCNA.  (A)  Confocal  fluorescence  images  of  full-length 
hABH2-YFP with endogenous PCNA (row 1) and hABH2 constructs co-
expressed with CFP-PCNA in live cycling HeLa cells. Insets show a higher 
magnification view of boxed regions. Bar, 5 µm. (B) Co-IP of PCNA from 
HeLa  cells  stably  expressing  hABH2-YFP  constructs  using  -YFP  beads.   
(C) Co-IP of hABH2 from cells stably expressing YFP-PCNA using -YFP 
beads. (D) Co-IP of hABH2 from cells only expressing endogenous proteins 
using -PCNA beads. Input is 3.3% of cell extract used for IP. Black lines, 
separate membranes; gray lines, same membranes.
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Figure 2.  Close interaction between the N terminus of hABH2 and a modified form of PCNA. (A) Sequence alignment of the 10 N-terminal amino acids 
of ABH2 homologues from different species (colors as given by Clustal X). (B) PCNA binding to hABH21–10 peptide variants (dot blot). Row 1 shows the 
hABH21–10 peptide, and rows 2–8 show peptides where different amino acids are substituted (underlined in the right panel; data from one membrane). 
(C) Confocal images of HeLa cells. Row 1 shows hABH21–7-YFP expressed alone (live cells), row 2 shows hABH21–7-YFP with endogenous PCNA, and 
rows 3–6 show various hABH21–7-YFP F4 variants coexpressed with CFP-PCNA (live cells). Insets show a magnified view of the boxed areas. Bars, 5 µm. 
(D) NFRET measurements. YFP/CFP (vectors only) and YFP-PCNA/CFP-PCNA were used as background and positive controls, respectively. Data shown 649 A NOVEL PCNA-BINDING MOTIF • Gilljam et al.
either one of the four APIMs of TFII-I, did not cause visible 
reduction  in  colocalization  with  PCNA  when  cotransfected 
with PCNA alone (unpublished data), but a reduction in FRET 
could be detected in these cases (Fig. 4 B, green). Thus, higher 
FRET between PCNA and WT proteins, and the fact that WT 
proteins outcompete the mutant proteins for binding to PCNA 
when coexpressed (Fig. 4 A, rows 3 and 4), suggested that the 
affinity of the mutant proteins for PCNA was reduced. Only a 
minor reduction in colocalization with PCNA was observed for 
the mutant Topo II  when coexpressed with WT Topo II . 
However, a reduction in FRET was also detected in this case 
(Fig. 4 B). Because Topo II  is a homodimer (Nettikadan et al., 
1998), binding to PCNA could be mediated through its non-
mutated endogenous or coexpressed WT partner. Altogether, 
these results strongly suggest that APIM is a functional PCNA- 
binding motif in all these proteins.
The RAD51B S phase spots were on average less bright 
than the spots for the other APIM-containing proteins, and 
clear colocalization with PCNA was seen in only 20% of the 
S phase cells in comparison with 95–100% for hABH2, TFIIS-L, 
TFII-I, and Topo II . This indicates that the PCNA–RAD51B 
interaction is less prominent and might require specific cell 
conditions.
In summary, the work presented in this study strongly indi-
cates that APIM is a functional, widespread PCNA-interacting 
motif found in many proteins involved in genome maintenance. 
Among other interesting APIM-containing proteins are the 
poly(ADP-ribose) family (PARP-1, -2, and -4), the FANCC pro-
tein, the REV3L subunit of translesion polymerase , several E3 
ubiquitin protein ligases, subunits of the general transcription 
factors II and III, members of the MAPK pathway, many serine/
threonine protein kinases, and three subunits of RNA poly-
merase II and III (Table I). Interestingly, recent data indicate 
a partial overlap between regions of replication and transcrip-
tion (Malyavantham et al., 2008); thus, APIM could possibly 
be involved in linking transcription and cell cycle regulation to 
PCNA/replicative processes after genotoxic stress.
The scaffold protein PCNA interacts with numerous pro-
teins in a well-orchestrated fashion, thus constituting a foun-
dation for many vital cellular processes. Interactions with PCNA 
are likely to be regulated at several levels; e.g., by PTMs as 
well as through several PCNA-interacting motifs (Moldovan 
et al., 2007). Interestingly, PCNA-binding peptides containing 
the PIP box fused to GFP are reported to block colony forma-
tion when expressed in untreated freely cycling HeLa and 
U2OS cells (Warbrick, 2006). Cells expressing APIM-YFP 
had normal capacity for colony formation in untreated cells, 
but these cells showed increased sensitivity to alkylating agents. 
We suggest that impaired PCNA binding of several APIM-
containing proteins, in addition to hABH2, contributes to the 
APIM is found in many proteins involved in 
genome maintenance and cell cycle control
Using the APIM motif as the query, we obtained 636 hits in the 
Swiss-Prot/TrEMBL database. After discarding nonnuclear 
proteins and proteins in which APIM is not conserved, this was 
reduced to 226 hits (Table I; see http://tare.medisin.ntnu.no/
pcna/index.php  for  complete  query  results  and  experimental 
procedures). Nine of these proteins also contained the PIP box 
consensus (Table I).
Among the proteins found in the query, we examined the 
APIMs more closely in four human proteins in addition to 
hABH2. We named the first protein examined TFIIS-like 
(TFIIS-L) because it contains the conserved N-terminal do-
main I found in elongation factor TFIIS (Cramer, 2004). The 
function of this protein is unknown. However, like hABH2, 
TFIIS-L contains an APIM within its seven N-terminal amino 
acids. We next examined the multifunctional transcription fac-
tor TFII-I, which contains four APIMs. TFII-I is a transcription 
factor critical for cell cycle control and proliferation and has 
also recently been suggested to have a role in DNA repair 
(Desgranges and Roy, 2006). Finally, we examined APIM in 
DNA topoisomerase (Topo) II , which is involved in post-
replicative DNA decatenation and DNA segregation (Agostinho   
et al., 2004), and the RAD51 paralogue RAD51B, which is in-
volved in homologous recombination, centrosome function, 
and chromosome segregation (Date et al., 2006). The APIM 
sequences in all these proteins are conserved throughout evolu-
tion (Fig. 3 D). Among these proteins, only Topo II  has been 
reported to localize to nuclear S phase foci (Lou et al., 2005) 
and  to  contain  a  putative  PIP  box  (QttLaFkp;  amino  acids 
1,277–1,284; Niimi et al., 2001). We cloned the proteins as 
YFP fusions and found that all were nuclear proteins accumu-
lating in various numbers of visible foci (Fig. 3 D), many of 
which represent replication foci (see following paragraph).   
Endogenous TFII-I was also present in foci colocalizing with 
endogenous PCNA (unpublished data).
APIM is a functional  
PCNA-interacting motif
Substitution of Phe4 to Ala in APIM impaired binding between 
hABH2-derived peptides and PCNA (Fig. 2); thus, we wanted 
to examine whether the corresponding mutation had a similar 
effect on the full-length hABH2, TFIIS-L, TFII-I (in one and 
four APIMs), Topo II , and RAD51B. Mutation of APIM in all 
these proteins, except Topo II , strongly reduced colocaliza-
tion with PCNA when coexpressed with WT proteins (Fig. 4 A, 
rows 2–7), suggesting that impaired APIM reduced the PCNA 
interaction. However, coexpression of WT hABH2-CFP and 
WT hABH2-YFP resulted in foci containing both fusion pro-
teins (Fig. 4 A, row 1). Mutations of APIM in TFIIS-L, or in   
are the result of three individual experiments (mean ± SEM; n = 35–50). (E) Cross-linked and reverse cross-linked IPs (-Flag) from cells stably expressing 
hABH21-–7YFP-Flag and hABH21-–7F4A-YFP-Flag. The eluted fractions were analyzed for the presence of PCNA and Flag fusion proteins by WB. (F) 2D gel 
electrophoresis followed by WB analysis of PCNA immunoprecipitated from cross-linked hABH21–7-YFP-Flag (top membrane; -Flag) and hABH21–7F4A-
YFP-Flag (mid membrane; -Flag). Total PCNA was immunoprecipitated with -PCNA beads (lower membrane). Purified recombinant RAD51 (rRAD51) 
was added as an internal standard. Dotted lines illustrate the vertical alignment of the membranes. (B and E) Gray lines indicate that intervening lanes 
have been spliced out.
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hypersensitivity to cytostatic drugs seen in APIM-expressing 
cells and that coordinated binding of APIM-containing pro-
teins to PCNA might be an important response mechanism 
subsequent to DNA damage.
Materials and methods
Expression constructs
Cloning  of  the  fluorescently  tagged  expression  constructs  CFP-PCNA, 
Hereactis  crispa  RFP  (HcRed)–PCNA,  and  hABH21–261-YFP/-CFP  has 
been  described  previously  (Aas  et  al.,  2003;  Otterlei  et  al.,  2006).   
Using phABH21–261-YFP as a template, phABH21–10-YFP and phABH211–261- 
YFP were generated by PCR and cloned into pYFP-N1 (Clontech Lab-
oratories,  Inc.)  using  NdeI–AgeI  and  AgeI–EcoRI,  respectively.  The 
PCR product from EST (image clone 5176979 [BC035374] Resource   
Center/Primary  Database)  was  cloned  into  pYFP-  and  pCFP-C1   
(HindIII–Acc651) to make pYFP- and pCFP–TFIIS-L. pTFII-I–YFP and –CFP 
were  generated  by  PCR  amplification  of  TFII-I  from  pI3CX–TFII-I  (pro-
vided by R.G. Roeder, The Rockefeller University, New York, NY) and   
cloning into pYFP- and pCFP-N1 (SacI–ApaI). pYFP– and pCFP–Topo II  
were made by switching the EGFP tag (EcoRI blunt–NheI) with YFP and 
CFP tag (XhoI blunt–NheI) from pEGFP–Topo II  (pT104-1; provided by 
Figure 3.  Expression of APIM decapeptide sensitizes cells to alkylating agents, and several foci-forming proteins contain conserved APIM. (A) 1meA in 
DNA isolated from YFP (closed squares)- and hABH21–10-YFP (open circles)–expressing cells after exposure to 1.2 mM MMS for 1 h before release from 
the G1/S border (mean ± SEM; n = 4–5). (B) Clonogenic assay comparing the MMS sensitivity between cells expressing hABH21–10-YFP (open circles), 
hABH21–7F4A-YFP (closed triangles), or only YFP (closed squares; mean ± SD; n = 2–4). CFU, colony-forming unit. (C) Cell growth of HeLa cells stably 
expressing YFP (closed squares) and hABH21–10-YFP (open circles) measured by MTT assay after continuous exposure to MMS, BCNU, MMC, and TMZ. 
The growth rates of unexposed cells are shown in the right lane. (D) Conservation of APIM in TFIIS-L, TFII-I, Topo II , and RAD51B. These proteins are 
shown as YFP fusion proteins. Bar, 5 µm.651 A NOVEL PCNA-BINDING MOTIF • Gilljam et al.
W.T. Beck, University of Illinois, Chicago, IL). RAD51B was amplified by 
PCR from pET15b-RAD51B (provided by S. Yokoyama, RIKEN Genomic   
Sciences Center, Kanagawa, Japan) and cloned into pYFP- and pCFP-N1 
using XhoI and SacII. The hABH21–7-YFP constructs, including the F4 
mutants, were made by annealing oligos with XhoI–EcoRI overhang   
followed by cloning into pYFP-N1 mutated in the ATG codon. The Flag 
constructs were generated by PCR amplification of the 3× Flag tag from 
p3×Flag–CMW-14 (Sigma-Aldrich) followed by cloning into pCFP-N1 
in the BsrGI–XbaI site. All point mutations were made by site-directed 
mutagenesis  (QuickChange  II;  Agilent  Technologies)  according  to  the 
manufacturer’s instructions. Restriction enzymes and calf intestinal alka-
line phosphatase were obtained from New England Biolabs, Inc., and 
the oligonucleotides were obtained from MedProbe Eurogentech. All con-
structs were verified by sequencing.
Confocal imaging
HeLa  cells  were  examined  16–48  h  after  transient  transfection  (by   
Fugene 6 [Roche] or Lipofectamine 2000 [Invitrogen] according to the 
manufacturer’s recommendations) of CFP, YFP, and HcRed fusion con-
structs. Fluorescent images were aquired using a laser-scanning micro-
scope (LSM 510 Meta; Carl Zeiss, Inc.) equipped with a Plan Apochromat 
63× 1.4 NA oil immersion objective. The images were acquired in the 
growth medium of the cell with the stage heated to 37°C using LSM 510 
software (Carl Zeiss, Inc.). For the two-color images, CFP was excited at 
 = 458 nm and detected at  = 470–500 nm, and YFP was excited at 
 = 514 nm and detected at  = 530–600 nm using consecutive scans. 
When three-color images were acquired, YFP was excited at  = 488 nm 
and detected at  = 530–600 nm, HcRed was excited at  = 543 nm   
and detected at  > 560 nm, and the CFP settings were kept as for the 
Table I.  Selected proteins containing APIM
Type/group of proteins Proteins Source
Proteins containing PIP box  
and APIM
DNA ligase I, MDN1 Midasin, ubiquitin thioesterase FAF-X,  
  protein 18 homologue (hVPS18), cytokine signaling 6 (SOCS-6),  
  Topo II , IB-related protein, UHRF2, PARP4
Moldovan et al., 2007
DNA polymerase Pol  catalytic subunit (hREV3L) Moldovan et al., 2007
DNA ligases DNA ligase I, DNA ligase IV Moldovan et al., 2007
Topo Topo II  and  This study; Niimi et al., 2001;  
  Lou et al., 2005 
DNA repair proteins hABH2, PARP-1, -2, and -4, RAD51B, FANCC, XPA This study;  
  Simbulan-Rosenthal et al., 1999;  
  Jacquemont and Taniguchi, 2007
DNA repair–associated/  
interacting proteins
XPA-binding protein 2, BRCA1/BRCA2-containing  
  complex subunit 45 (prot-BRE), x-ray radiation  
  resistance-associated protein 1
NA
Sister chromatid cohesion N-acetyltransferase ESCO1/EFO1, hSMC5 Potts et al., 2006;  
  Moldovan et al., 2007
Chromatin remodelling and  
DNA-binding proteins
Chromodomain helicase DNA-binding proteins 3–5,  
  p325 subunit of remodeling and spacing factor  
  chromatin–remodelling complex, telomeric repeat–binding  
  protein 2 (TRF2)
Opresko et al., 2004
E3 ubiquitin ligases UHFR1, UHFR2, UBR1, UBR2, ring finger proteins 3, 17,  
  and 151, probable E3 ubiquitin protein ligase MYCBP2
Bronner et al., 2007
Transcription factors TFIIS-L, TFII-I, TFIIE-, sterol regulatory element-binding  
  transcription factor 2 (SREBF2), TFIIIC subunit , TFIID 100 kD  
  subunit (TAF5), TFIIIC 102 kD subunit (TF3C ), transcription  
  factor–like protein MRG15 and X (mortality factor 4–like proteins  
  1 and 2), E2 transcription factor 7
This study
Cell cycle regulators Cell division cycle-associated 2, Bcl2-interacting mediator  
  of cell death, testis spermatocyte apoptosis-related gene 2 protein
NA
Protein kinases Serine/threonine (S/T) protein kinases SRPK1 and -2, 33  
  and MST4, leucine-rich repeat S/T protein kinase 1, STK23  
  (S/T protein kinase 23), S/T protein kinase PLK3,  
  microtubuli-associated S/T protein kinase, microtubuli-associated  
  S/T protein kinase 1, MAPKAP kinase 2 (MK2) and 5 (MK5),  
  mitogen-activated protein kinase 15 (MSK-15)
NA
Methyltransferase H3 lysine 4–specific MLL3, H3-K9 methyltransferase 5,  
  putative rRNA methyltransferase 3
NA
Cancer-associated antigens Melanoma-associated antigen E1 (MAGE E1), MAGE B18,  
  MAGE-G1, natural killer tumor recognition protein (NK-TR),  
  Myc-binding protein–associated protein, Myb-binding  
  protein 1A, hepatoma-derived growth factor–related protein 2  
  isoform1, serologically defined colon cancer antigen 1
NA
RNA polymerase and  
ribosome-associated  
proteins
RNA polymerase II, largest subunit (RPB1), RNA polymerase III  
  subunit 5 (RPC5), RNA polymerase II 140 kD (RPB2), UTP14A U3  
  small nucleolar RNA-associated protein 14 homologue A,  
  60S ribosomal protein L18, 60S ribosomal protein L35,  
  TAF5-like RNA polymerase II p300 (PAF65-beta), mediator of 
  RNA polymerase II  
  transcription subunit 12 homologue
NA
NA, not applicable. Bold indicates proteins localized in replication foci under normal conditions or after DNA damage. The full lists of hits for the APIM and PIP motifs 
are available at http://tare.medisin.ntnu.no/pcna/index.php.JCB • VOLUME 186 • NUMBER 5 • 2009   652
two-color images. The thickness of the slice was 1 µm. No image process-
ing, except contrast and intensity adjustments, were performed.
Immunofluorescence
HeLa cells were fixed in freshly made 2% paraformaldehyde on ice for   
10 min before cold (20°C) methanol was added, and the cells were 
incubated  at  20°C  for  20  min.  All  dilutions  and  washes  were  per-
formed in 2% FCS in PBS. The cells were washed (three times for 5 min) 
before addition of 1 µg/ml -PCNA (PC10; Abcam) and incubation for 
1 h at 37°C. Finally, the cells were incubated for 1 h at 37°C with the 
secondary antibody Alexa Fluor 546 goat anti–mouse (diluted 1:2,000; 
Invitrogen). After washing, the cells were analyzed in a laser-scanning 
microscope (LSM 510 Meta; described in the previous paragraph), with 
excitation at 546 nm and detection >560 nm for goat anti–mouse and 
488 nm excitation and detection between 505 and 550 nm for YFP,   
using consecutive scans.
FRET measurements
FRET occurs if the tags (YFP and CFP) are <100 Å (10 nm) apart (Mátyus, 
1992). We detected FRET using the sensitized emission method, measuring 
acceptor (YFP) emission upon donor (CFP) excitation. FRET was scored 
when the intensity of emitted light from YFP after excitation of the CFP fluoro-
chrome was stronger than the light emitted by CFP- or YFP-tagged proteins 
alone after excitation with the YFP and CFP lasers, respectively (bleed 
through), given by the equation FRET = I2  I1 (ID2/ID1)  I3 (IA2/IA3), in 
which I indicates mean intensities. YFP and CFP (vectors only) were used to 
measure background FRET because of dimerization of the tags, and YFP-
PCNA and CFP-PCNA (because PCNA is a homotrimer) were used as posi-
tive  control.  FRET  >  0  was  normalized  for  expression  levels  using  the 
equation NFRET = FRET/(I1 × I3)
1/2 (Mátyus, 1992; Xia and Liu, 2001;   
Otterlei et al., 2006). NFRET was calculated from mean intensities within a 
region of interest containing >25 pixels in which all pixels had intensities 
<250, and the mean intensities were between 100 and 200. Channels 1 
(CFP) and 3 (YFP) were measured as described for imaging, and channel 2 
(FRET) was excited with  = 458 nm and detected at  = 530–600 nm. 
ID1–D3 and IA1–A3 were determined for cells transfected with CFP and YFP 
constructs only with the same settings and fluorescence intensities as co-
transfected cells (I1 and I3).
Culture of cell lines and preparation of cell extracts
HeLa (cervical cancer) cells stably expressing the constructs of interest 
were prepared by transfection (Fugene 6) followed by cell sorting or 
cloning  by  dilution,  and  prolonged  culturing  in  400  µg/ml  selective   
(using genticine; G418; Invitrogen) high glucose, 4.5 g/liter DME (Bio-
Whittaker)  supplemented  with  10%  FCS,  250  µg/ml  amphotericin  B 
(Sigma-Aldrich), 100 µg/ml gentamycin (Invitrogen), and 1 mM gluta-
mine (BioWhittaker). The cells were cultured at 37°C in a 5% carbon 
dioxide–humidified  atmosphere.  Fractionated  cell  extracts  from  HeLa 
were prepared by resuspending the cell pellets in 1× packed cell vol-
ume (PCV) in buffer I (10 mM Tris-HCl, pH 8.0, and 50 mM KCl) and 
1× PCV in buffer II (10 mM Tris-HCl, 100 mM KCl, 20% glycerol, 0.5% 
Nonidet P-40, 10 mM EGTA, 10 mM MgCl2, 1 mM DTT, 1× complete 
protease  inhibitor  [Roche],  and  phosphatase  inhibitor  cocktail  [PIC  I 
and II; Sigma-Aldrich]). Cells were incubated under constant shaking for   
30 min at 4°C, centrifuged at 2,000 rpm, and the supernatant (soluble 
fraction) was harvested. The pellet (containing nuclei) was resuspended 
in 1× PCV of buffer III (10 mM Tris-HCl, pH 8.0, and 100 mM KCl), 1× 
PCV buffer II, and sonicated. The sonicated nuclear pellet was incubated 
with 2 µl DNase/RNase cocktail I (200 U/µl Omnicleave Endonuclease; 
Epicentre Technologies), 1 µl DNase (10 U/µl; Roche), 1 µl bensonase 
(250 U/µl; EMD), 1 µl micrococcal nuclease (100–300 U/mg; Sigma-
Aldrich), and 10 µl RNase (2 mg/ml; Sigma-Aldrich) per 30 mg cell 
extract at 37°C for 1 h. This fraction, denoted chromatin-enriched frac-
tion, was dialyzed against buffer II and III followed by clearance by 
centrifugation before IP.
Figure 4.  Point mutations in APIM result in disrupted colocalization and 
reduced FRET.  (A)  Row  1  shows  confocal  images  of  cotransfected  WT 
hABH2-CFP, WT hABH2-YFP, and HcRed-PCNA. Rows 2–7 show confocal 
images of the WT proteins with CFP tag (left; green) cotransfected with YFP-
tagged proteins mutated in APIM (middle; green), and HcRed-PCNA (right; 
red) in live cycling HeLa cells. Insets show merged images with PCNA.   
Bar, 5 µm. (B) NFRET calculated for constructs in which single APIM mutation 
does not disrupt colocalization. WT and mutant proteins (YFP fusions of 
TFIIS-L, TFII-I, and Topo II ) are coexpressed with CFP-PCNA. YFP/CFP 
(vectors only) were used as background. Data are the results of two (TFIIS-L 
and TFII-I) to four (Topo II ) independent experiments. Error bars indicate 
mean ± SEM (n = 36–119).
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Sigma-Aldrich), and -Flag (monoclonal; Sigma-Aldrich), as well as the 
secondary antibodies, polyclonal rabbit anti–mouse IgG/HRP and poly-
clonal swine anti–rabbit IgG/HRP (Dako), were diluted in 1% dry milk in 
PBST. The membranes were treated with chemiluminescence reagent   
(SuperSignal West Femto Maximum; Thermo Fisher Scientific), and the pro-
teins were visualized in Image Station (2000R; Kodak).
Dot blot analysis of predicted PCNA-binding peptides
An amino PEG500-UC540 sheet (acid hardened with improved stability) 
containing dots of 28 nmol peptide (stained with Ponceau to visualize the 
spots) was prepared at the peptide synthesis laboratory at The Biotechnol-
ogy Center (University of Oslo, Oslo, Norway). The membrane was probed 
with 1 µg/ml PCNA for 2 h followed by probing with -PCNA (PC10) and 
developed as described for WB. Data extracted from one representative 
dot blot is shown.
Sequence analysis
Details are provided at http://tare.medisin.ntnu.no/pcna/index.php.
MTT assay
HeLa  cells  stably  expressing  hABH21–10-YFP  and  YFP  were  seeded 
into 96-well plates (4,000 cells/well) and incubated for 3 h. Various 
doses of MMS (Acros Organics), BCNU (1,3-Bis(2-chloroethyl)-1-nitro-
surea; Sigma-Aldrich), TMZ (4-methyl-5-oxo-2,3,4,6,8-pentazabicyclo 
[4.3.0]  nona-2,7,9-triene-9-carboxamide;  Sigma-Aldrich),  and  MMC 
(6-amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a-methoxy-5-
methyl-azirino[2’,3:3,4]  pyrrolo[1,2-a]indole-4,7-dione  carbamate; 
Sigma-Aldrich) were added to the wells. The cells were exposed con-
tinuously until harvest. MTT was added to the cells, the OD was mea-
sured at 570 nm, the mean from at least six wells was used to calculate 
cell survival, and the SD was smaller than the size of the dots. Data 
presented show growth from one representative experiment and has 
been reproduced at least two times.
Clonogenic assay
750 cells were seeded out in 10-cm cell culture dishes in 10 ml growth   
media and grown for 10 d. The cells were fixed in 6% glutaraldehyde in 
PBS for 15 min at room temperature, washed once in PBS, and stained 
with crystal violet, and colony-forming units were counted. Only colonies 
consisting of at least 50 cells were included. Data presented are mean ± 
SD from two (hABH21–7F4A-YFP) and four (hABH21–10-YFP and YFP) inde-
pendent experiments.
Quantitation of 1meA in DNA
HeLa cells stably expressing hABH21–10-YFP and YFP were synchronized by 
the double thymidine block and analyzed by flow cytometry to verify the 
cell cycle phase. The DNA analysis of the cells was performed after metha-
nol fixation (70%), RNase treatment (100 µg/ml in PBS at 37°C for 30 
min), and propidium iodide staining (50 µg/ml in PBS at 37°C for 30 min) 
on an FACS flow cytometer (Canto; BD).
During G1/S arrest, the cells were treated with 1,200 µM MMS   
for 1 h, released, and harvested at defined time points. The cell pellets 
were washed with ice-cold PBS, spun down, snap frozen in liquid N2, and 
stored at 80°C before use. DNA was isolated using DNeasy Blood   
and Tissue kit (QIAGEN). DNA samples were degraded enzymatically 
to deoxynucleosides and analyzed by LC/MS/MS using an HPLC system 
(Prominence; Shimadzu) interfaced with a triple-quadrupole mass spec-
trometer (API5000; Applied Biosystems), essentially as described previously 
(Ringvoll et al., 2006). 1meA and unmodified deoxynucleosides were 
monitored in multiple-reaction monitoring mode using the mass transitions 
266.2→150.1 (1meA), 252.2→136.1 (deoxyadenosine), 243.2→127.1 
(thymidine), 268.2→152.1 (deoxyguanosine), and 228.2→112.1 (deoxy-
cytidine). Quantization was accomplished by comparison with pure deoxy-
nucleoside standards.
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Formaldehyde cross-linking of proteins in intact cells
Cells were harvested and washed twice with cold PBS. 5–6 × 10
6 cells were 
resuspended in 10 ml PBS containing 0.25% formaldehyde and incubated 
at 37°C for 20 min. Cross-linking was stopped by adding glycine (final con-
centration 0.125 M). Cells were collected by centrifugation and washed 
once in PBS, resuspended in 8× PCV in buffer (20 mM Hepes, pH 7.9,   
1.5 mM MgCl2, 100 mM KCl, 0.2 mM EDTA, 20% glycerol, 0.5% NP-40, 
1 mM DTT, and complete protease inhibitor) containing 5 µl Omnicleave, 
and sonicated. DNase/RNase cocktail I was added, and the homogenate 
was incubated at room temperature for 1 h and dialyzed at 4°C overnight 
in buffer (20 mM Hepes, pH 7.9, 1.5 mM MgCl2, 100 mM KCl, 0.2 mM 
EDTA, 10% glycerol, 1 mM DTT, and complete protease inhibitor).
co-IP
An in-house affinity-purified rabbit polyclonal antibody raised against GFP 
protein, which also recognizes YFP and CFP proteins (called -YFP), and 
monoclonal  -PCNA  antibody  (PC10;  Santa  Cruz  Biotechnology,  Inc.) 
were covalently linked to protein A paramagnetic beads (Invitrogen) ac-
cording to instructions provided by New England Biolabs, Inc. 1,500 µg 
total cell–protein of the fractions was incubated with an additional 2 µl 
Omnicleave during IP with 10 µl antibody-coupled beads under constant 
rotation at 4°C over night (IP). The beads were washed four times with 200 µl 
10 mM Tris-HCl and 50 mM KCl, pH 8, with a 5-min incubation on ice 
in between. The beads were resuspended in NuPAGE (Invitrogen) loading 
buffer and 1 mM DTT, heated, and the IP elutions were separated on   
4–12% Bis-Tris-HCl (NuPAGE) gels. 50 µg cell extract was used for input.
IP of cross-linked protein extracts
Cross-linked Flag fusion proteins were immunoprecipitated using anti-Flag 
M2 affinity gel (herein referred to as -Flag; Sigma-Aldrich) according to 
the manufacturer’s protocol. The resin was prepared by washing once with 
0.1 M glycine and 0.5 M NaCl, pH 3.0, and three times with TBS buffer 
(50 mM Tris HCl, pH 7.4, 150 mM NaCl, 10 mM Na butyrate, and   
20 mM NaF). 2.5 mg and 5 mg (hABH21–7-YFP and hABH21–7F4A-YFP,   
respectively) of cross-linked extracts were incubated with 20 µl or 40 µl 
resin, respectively (packed gel volume), for 2 h at 4°C under constant rota-
tion. The resin was washed three times with 500 µl of TBS buffer, and the 
cross-linked Flag fusion proteins were eluted by incubating the resin with 
100 µl 3× Flag peptide in TBS buffer (final concentration of 450 ng/µl) for 
30 min at 4°C under constant rotation. The cross-linking was reversed by 
a 30-min incubation at 95°C. For further WB analyses, the IP elution frac-
tions were heated in 1× LDS sample buffer (NuPAGE) and 0.1 M DTT 
(65°C for 10 min) before loading 4–12% Bis-Tris-HCl (NuPAGE) gels.
2D gel electrophoresis
Immunoprecipitates of cross-linked extracts of hABH21–7YFP–3× Flag   
(5 mg) and hABH21–7F4A-YFP-3× Flag (10 mg) pulled down with -Flag 
resin (40 µl and 80 µl, respectively) and by magnetic -PCNA–coupled 
beads (50 µl beads; 2 mg extract) was subjected to 2D Western analysis. 
The resin was washed three times with 500 µl of TBS buffer. The resin was 
washed once in 20 mM Tris HCl, pH 7.4, 50 mM NaCl, 10 mM Na buty-
rate, and 20 mM NaF, and the cross-linked Flag fusion proteins were eluted 
by incubating the resin with 100 µl 3×Flag peptide in this buffer (final con-
centration of 450 ng/µl) for 30 min at 4°C under constant rotation. First di-
mension: after IP and elution, the cross-links were reversed (see previous 
paragraph), the -PCNA beads were washed three times with 10 mM Tris-HCl 
and 50 mM KCl (1 ml), and resuspended in 340 µl destreak with 1% 
IPG buffer, pH 4–7 (GE Healthcare). After incubation overnight in a shaker 
at  4°C,  the  elutions  were  collected  in  separate  vials  without  -PCNA 
beads. 20 ng recombinant RAD51 protein (molecular mass, 37 kD;   
pI, 5.4; provided by I. Hickson Weatherall, University of Oxford, Oxford, 
England, UK) was added to each sample to serve as an internal standard. 
The samples were used to rehydrate immobiline DryStrips (18 cm; pH 4–7; 
GE Healthcare) overnight. The isoelectric focusing was performed accord-
ing to the manufacturer’s instructions in the IPGphor II unit (GE Healthcare). 
After isoelectric focusing, strips were cut after pH 5.5, and the pieces from 
pH 4–5.5 were incubated in equilibrium buffer (50 mM Tris-HCl, pH 8.8, 
6 M urea, 30% glycerol, and 2% SDS) containing 1% DTT for 15 min fol-
lowed by a 15-min incubation in the same buffer containing 2.5% iodo-
acetamide instead of DTT. Second dimension: the strips were loaded onto 
NuPAGE Novex 4–12% gels (Invitrogen).
WB
After gel electrophoresis, the polyvinylidene fluoride membranes (Immobi-
lon; Millipore) were blocked in 5% low fat dry milk in PBST (PBS with 0.1% 
Tween 20). The primary antibodies, -PCNA (PC10), -hABH2 (monoclonal; JCB • VOLUME 186 • NUMBER 5 • 2009   654
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